100 related articles for article (PubMed ID: 2001833)
1. Comparison of collagen propeptides as growth markers in children with inflammatory bowel disease.
Hyams JS; Treem WR; Carey DE; Wyzga N; Eddy E; Goldberg BD; Moore RE
Gastroenterology; 1991 Apr; 100(4):971-5. PubMed ID: 2001833
[TBL] [Abstract][Full Text] [Related]
2. Serum concentrations of the type I and III procollagen propeptides as biochemical markers of growth velocity in healthy infants and children and in children with growth disorders.
Trivedi P; Risteli J; Risteli L; Hindmarsh PC; Brook CG; Mowat AP
Pediatr Res; 1991 Sep; 30(3):276-80. PubMed ID: 1945568
[TBL] [Abstract][Full Text] [Related]
3. Relationship of type I procollagen to corticosteroid therapy in children with inflammatory bowel disease.
Hyams JS; Moore RE; Leichtner AM; Carey DE; Goldberg BD
J Pediatr; 1988 Jun; 112(6):893-8. PubMed ID: 3373393
[TBL] [Abstract][Full Text] [Related]
4. Type 1 procollagen as a biochemical marker of growth in children with inflammatory bowel disease.
Hyams JS; Carey DE; Leichtner AM; Goldberg BD
J Pediatr; 1986 Oct; 109(4):619-24. PubMed ID: 3761075
[TBL] [Abstract][Full Text] [Related]
5. Serum concentrations of carboxyl-terminal propeptide of type I procollagen, amino-terminal propeptide of type III procollagen, cross-linked carboxyl-terminal telopeptide of type I collagen, and their interrelationships in schoolchildren.
Crofton PM; Wade JC; Taylor MR; Holland CV
Clin Chem; 1997 Sep; 43(9):1577-81. PubMed ID: 9299936
[TBL] [Abstract][Full Text] [Related]
6. Growth velocity, growth hormone therapy, and serum concentrations of the amino-terminal propeptide of type III procollagen.
Trivedi P; Hindmarsh P; Risteli J; Risteli L; Mowat AP; Brook CG
J Pediatr; 1989 Feb; 114(2):225-30. PubMed ID: 2915282
[TBL] [Abstract][Full Text] [Related]
7. Long-term monitoring of treatment with recombinant human growth hormone by serial determinations of type III procollagen-related antigens in serum.
Danne T; Grüters A; Schnabel K; Burger W; L'Allemand D; Enders I; Helge H; Weber B
Pediatr Res; 1988 Feb; 23(2):167-71. PubMed ID: 3353159
[TBL] [Abstract][Full Text] [Related]
8. Serum concentrations of type I and III procollagen propeptides in healthy children and girls with central precocious puberty during treatment with gonadotropin-releasing hormone analog and cyproterone acetate.
Hertel NT; Stoltenberg M; Juul A; Main KM; Müller J; Nielsen CT; Lorenzen I; Skakkebaek NE
J Clin Endocrinol Metab; 1993 Apr; 76(4):924-7. PubMed ID: 8473407
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal assessment of type I procollagen in children with inflammatory bowel disease subjected to surgery.
Hyams JS; Moore RE; Leichtner AM; Carey DE; Goldberg BD
J Pediatr Gastroenterol Nutr; 1989 Jan; 8(1):68-74. PubMed ID: 2732865
[TBL] [Abstract][Full Text] [Related]
10. Procollagen type III amino-terminal propeptide: a serum biomarker of left ventricular remodelling in paediatric dilated cardiomyopathy.
Kaufman BD; Videon N; Zhang X; Harris MA; Shaddy RE; Goldmuntz E
Cardiol Young; 2015 Feb; 25(2):228-36. PubMed ID: 24192074
[TBL] [Abstract][Full Text] [Related]
11. Type I and III procollagen propeptides in growth hormone-deficient patients: effects of increasing doses of GH.
Jensen LT; Jørgensen JO; Risteli J; Christiansen JS; Lorenzen I
Acta Endocrinol (Copenh); 1991 Mar; 124(3):278-82. PubMed ID: 2011916
[TBL] [Abstract][Full Text] [Related]
12. Seromarkers of collagen I and III metabolism in active Crohn's disease. Relation to disease activity and response to therapy.
Kjeldsen J; Schaffalitzky de Muckadell OB; Junker P
Gut; 1995 Dec; 37(6):805-10. PubMed ID: 8537052
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of circulating type I procollagen propeptides in patients with Paget's disease of bone.
Bonnin MR; Moragues C; Nolla JM; Lirón FJ; Roig-Escofet D; Navarro MA
Clin Chem Lab Med; 1998 Jan; 36(1):53-5. PubMed ID: 9594087
[TBL] [Abstract][Full Text] [Related]
14. Twenty-four-hour osteocalcin, carboxyterminal propeptide of type I procollagen, and aminoterminal propeptide of type III procollagen rhythms in normal and growth-retarded children.
Saggese G; Baroncelli GI; Bertelloni S; Cinquanta L; DiNero G
Pediatr Res; 1994 Apr; 35(4 Pt 1):409-15. PubMed ID: 8047377
[TBL] [Abstract][Full Text] [Related]
15. Serum aminoterminal propeptide of type III procollagen: a potential predictor of the response to growth hormone therapy.
Tapanainen P; Risteli L; Knip M; Käär ML; Risteli J
J Clin Endocrinol Metab; 1988 Dec; 67(6):1244-9. PubMed ID: 3192681
[TBL] [Abstract][Full Text] [Related]
16. Relationship of procollagen type III propeptide-related antigens in serum to somatic growth in healthy children and patients with growth disorders.
Danne T; Grüters A; Schuppan D; Quantas N; Enders I; Weber B
J Pediatr; 1989 Feb; 114(2):257-60. PubMed ID: 2915284
[No Abstract] [Full Text] [Related]
17. Elevated serum PIIINP and laminin in inflammatory bowel disease indicate hepatobiliary and pancreatic dysfunction.
Heikius B; Niemelä O; Niemelä S; Karttunen TJ; Lehtola J
Hepatogastroenterology; 2002; 49(44):404-11. PubMed ID: 11995461
[TBL] [Abstract][Full Text] [Related]
18. Type I and type III procollagen propeptides in amniotic fluid of normal pregnancies and in a case of mild osteogenesis imperfecta.
Kauppila S; Tekay A; Risteli L; Koivisto M; Risteli J
Eur J Clin Invest; 1998 Oct; 28(10):831-7. PubMed ID: 9792997
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of serum hyaluronic acid and type I and III procollagen propeptides in extrahepatic biliary atresia.
Trivedi P; Dhawan A; Risteli J; Risteli L; Mirza M; Cheeseman P; Mowat AP
Pediatr Res; 1995 Oct; 38(4):568-73. PubMed ID: 8559611
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor axis, bone and collagen turnover in children with atopic dermatitis treated with topical glucocorticosteroids.
Wolthers OD; Heuck C; Ternowitz T; Heickendorff L; Nielsen HK; Frystyk J
Dermatology; 1996; 192(4):337-42. PubMed ID: 8864369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
